Polymeric Drug Delivery of Platinum-Based Anticancer Agents

被引：112

作者：

Haxton, Katherine J. ^{[1
,2
]}

Burt, Helen M. ^{[1
]}

机构：

[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada

[2] Keele Univ, Sch Phys & Geog Sci, Keele ST5 5BG, Staffs, England

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 2009年 / 98卷 / 07期

基金：

加拿大健康研究院; 加拿大自然科学与工程研究理事会;

关键词：

polymeric drug delivery systems; polymers; dendrimers; nanoparticles; biodegradable polymers; microparticles; macromolecular drug delivery; macromolecular prodrugs; micelle; PLGA-MPEG NANOPARTICLES; METAL COMPLEX MICELLE; ANTITUMOR-ACTIVITY; CLINICAL PHARMACOKINETICS; CISPLATIN DELIVERY; ESCHERICHIA-COLI; PROSTATE-CANCER; BLOCK-COPOLYMER; CELL-DIVISION; PHASE-I;

D O I：

10.1002/jps.21611

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Platinum-based anticancer agents such as cisplatin and carboplatin are in widespread clinical use but associated with many side effects. Improving the delivery of cytotoxic platinum compounds may lead to reduced side effects and achieve greater efficacy at lower doses. Polymer-based therapeutics have been investigated as potential drug delivery vehicles for platinum-based drugs. Against a background of the chemistry and pharmacology of cytotoxic platinum compounds, this review discusses the formation and properties of platinum-polymer complexes, dendrimers, micelles, and microparticulates. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2299-2316, 2009

引用

页码：2299 / 2316

页数：18

共 137 条

[41] The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects [J].

Hospers, GAP ;

Eisenhauer, EA ;

de Vries, EGE .

BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) :629-638

[42] Thermal decomposition of a generation 4.5 PAMAM dendrimer platinum drug conjugate [J].

Howell, B. A. ;

Fan, D. ;

Rakesh, Leela .

JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2006, 85 (01) :17-20

[43] Tumour-inhibiting platinum complexes-state of the art and future perspectives [J].

Jakupec, MA ;

Galanski, M ;

Keppler, BK .

REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 :1-53

[44] DRUG ACCUMULATION AND DNA PLATINATION IN CELLS EXPOSED TO AQUATED CISPLATIN SPECIES [J].

JENNERWEIN, M ;

ANDREWS, PA .

CANCER LETTERS, 1994, 81 (02) :215-220

[45] Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation [J].

Jeong, Young-Il ;

Kim, Seong-Taek ;

Jin, Shu-Guang ;

Ryu, Hyang-Hwa ;

Jin, Yong-Hao ;

Jung, Tae-Young ;

Kim, In-Young ;

Jung, Shin .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (03) :1268-1276

[46] Hydrolysis of oxaliplatin - Evaluation of the acid dissociation constant for the oxalato monodentate complex [J].

Jerremalm, E ;

Eksborg, S ;

Ehrsson, H .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) :436-438

[47] Polymeric drug carriers functionalized with pairwise arranged hydroxyl and/or carboxyl groups for platinum chelation [J].

Johnson, MT ;

Komane, LL ;

N'Da, DD ;

Neuse, EW .

JOURNAL OF APPLIED POLYMER SCIENCE, 2005, 96 (01) :10-19

[48] Cell growth-inhibiting properties of selected carrier-bound, monoamine-coordinated platinum(II) compounds [J].

Johnson, MT ;

Neuse, EW ;

van Rensburg, CEJ ;

Kreft, E .

JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS, 2003, 13 (02) :55-67

[49] Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates [J].

Jun, YJ ;

Kim, JI ;

Jun, MJ ;

Sohn, YS .

JOURNAL OF INORGANIC BIOCHEMISTRY, 2005, 99 (08) :1593-1601

[50] Broadening the clinical use of platinum drug-based chemotherapy with new analogues: satraplatin and picoplatin [J].

Kelland, Lloyd .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) :1009-1021

← 1 2 3 4 5 6 7 8 9 10 →